Bhatia Sangeeta N. — SEC insider filings

SEC reporting owner CIK 1643921. 21 insider filings on record with FilingPulse; latest filed 2026-11-18.

Transaction summary — filings shown

Covers all 21 filings on record, filed 2020-10-07 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
VERTEX PHARMACEUTICALS INC / MA (VRTX)Director21—46 legs · 20,815 sh · $6,494,42314

Insider filings — Bhatia Sangeeta N.

FiledFormIssuerReported transactionsSource
2026-11-184VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 271 @ $547.86EDGAR
2026-05-054VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 943 @ $0 · Sale (S): 318 @ $423.73EDGAR
2026-02-184VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 266 @ $500EDGAR
2025-08-294VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 266 @ $386.69EDGAR
2025-05-054VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 796 @ $0 · Sale (S): 400 @ $505.86EDGAR
2024-09-044VERTEX PHARMACEUTICALS INC / MA (VRTX)Option exercise (M): 646 @ $152.74 · Sale (S): 646 @ $500 · Option exercise (M): 646 (derivative) @ $0EDGAR
2024-08-124VERTEX PHARMACEUTICALS INC / MA (VRTX)Option exercise (M): 1,292 @ $152.74 · Sale (S): 1,292 @ $466.29 · Option exercise (M): 1,292 (derivative) @ $0EDGAR
2024-05-034VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 1,001 @ $0 · Sale (S): 467 @ $402.95EDGAR
2023-10-194VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 243 @ $375EDGAR
2023-10-114VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 242 @ $360EDGAR
2023-08-114VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 242 @ $345.51EDGAR
2023-05-034VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 1,168 @ $0 · Sale (S): 62 @ $345.93 · Sale (S): 172 @ $346.69 · Sale (S): 120 @ $348.16 · Sale (S): 163 @ $349.82 · Sale (S): 63 @ $351.20EDGAR
2022-10-264VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 621 @ $310EDGAR
2022-08-104VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 45 @ $290.18 · Sale (S): 164 @ $291.76 · Sale (S): 204 @ $293.15 · Sale (S): 161 @ $294.24 · Sale (S): 47 @ $295.53EDGAR
2022-08-024VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 99 @ $276.65 · Sale (S): 200 @ $277.95 · Sale (S): 160 @ $279.28 · Sale (S): 99 @ $280.22 · Sale (S): 58 @ $281.03 · Sale (S): 5 @ $282.34EDGAR
2022-05-044VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 40 @ $255.40 · Sale (S): 280 @ $257.51 · Sale (S): 120 @ $258.90 · Sale (S): 120 @ $259.75 · Sale (S): 80 @ $260.82 · Sale (S): 91 @ $261.91 · +1 moreEDGAR
2022-05-034VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 1,449 @ $0EDGAR
2022-04-124VERTEX PHARMACEUTICALS INC / MA (VRTX)Option exercise (M): 1,907 @ $125.71 · Sale (S): 1,907 @ $280.20 · Option exercise (M): 1,907 (derivative) @ $0EDGAR
2021-06-044VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 285 @ $208.96 · Sale (S): 153 @ $210.01 · Sale (S): 121 @ $211EDGAR
2021-05-044VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 1,842 @ $0EDGAR
2020-10-074VERTEX PHARMACEUTICALS INC / MA (VRTX)Option exercise (M): 8,729 @ $126.68 · Sale (S): 291 @ $262.66 · Sale (S): 594 @ $263.54 · Sale (S): 892 @ $264.60 · Sale (S): 1,787 @ $265.82 · Sale (S): 2,070 @ $266.66 · +3 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1643921 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs